RE: Come back18 Jun 2024 09:16
The fundraising, announced in March 2024, of Β£9.9m (before fees) was a significant focus during the period. We were pleased to raise these funds to support the Company's near-term activities in what were and continue to be challenging market conditions.
Challenging market conditions....what kind of garbage statement is that? Are less men being diagnosed with or getting prostate cancer, no of course not. Facts are they still can't sell test in any volume whatsoever....because its over priced and under validated.